Green Thumb Industries (GTBIF) Non-Current Deferred Tax Liability (2019 - 2026)

Green Thumb Industries (GTBIF) posted Non-Current Deferred Tax Liability of $220.6 million for Q1 2026, little changed on a QoQ basis from $220.6 million in Q4 2025, and up 180.58% year-over-year from $78.6 million in Q1 2025.

Green Thumb Industries (GTBIF) Non-Current Deferred Tax Liability (2019 - 2026) Analysis & Trends

Green Thumb Industries' Non-Current Deferred Tax Liability history runs 8 years deep, the most recent figure standing at $220.6 million for Q1 2026.

  • Quarterly Non-Current Deferred Tax Liability rose 180.58% year-over-year to $220.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $220.6 million (up 180.58% YoY) and the FY2025 annual result came in at $220.6 million, up 180.58% from the prior year.
  • Non-Current Deferred Tax Liability was $220.6 million for Q1 2026 at Green Thumb Industries, roughly flat from $220.6 million in the prior quarter.
  • Across five years, Non-Current Deferred Tax Liability topped out at $220.6 million in Q4 2025 and bottomed at $62.6 million in Q4 2022.
  • A 5-year average of $90.6 million and a median of $78.6 million in 2024 frame the typical range for Non-Current Deferred Tax Liability.
  • Annual changes were most pronounced in 2022 — Non-Current Deferred Tax Liability slipped 23.58% — and 2025, when it jumped 180.58%.
  • Green Thumb Industries' Non-Current Deferred Tax Liability stood at $62.6 million in 2022, then rose by 15.92% to $72.5 million in 2023, then increased by 8.43% to $78.6 million in 2024, then soared by 180.58% to $220.6 million in 2025, then changed by 0.0% to $220.6 million in 2026.
  • Business Quant data shows GTBIF's Non-Current Deferred Tax Liability at $220.6 million in Q1 2026, $220.6 million in Q4 2025, and $78.6 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Haleon 87.22 Bn 85.35 Bn -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn
10 Green Thumb Industries 1.63 Bn 1.29 Bn 143.65 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 220.60 Mn
Mar 31, 2026 220.60 Mn
Dec 31, 2025 220.60 Mn
Dec 31, 2025 220.60 Mn
Sep 30, 2025 78.62 Mn
Sep 30, 2025 78.62 Mn
Jun 30, 2025 78.62 Mn
Jun 30, 2025 78.62 Mn
Mar 31, 2025 78.62 Mn
Mar 31, 2025 78.62 Mn
Dec 31, 2024 78.62 Mn
Dec 31, 2024 78.62 Mn
Sep 30, 2024 72.51 Mn
Sep 30, 2024 72.51 Mn
Jun 30, 2024 72.51 Mn
Jun 30, 2024 72.51 Mn
Mar 31, 2024 72.51 Mn
Mar 31, 2024 72.51 Mn
Dec 31, 2023 72.51 Mn
Dec 31, 2023 72.51 Mn